(Q44117285)

30 November 2017

title

Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy (English)

1 reference

30 November 2017

Sargon Ziyeh

1

1 reference

30 November 2017

Thorsten Thiel

2

1 reference

30 November 2017

Joachim Spreer

3

1 reference

30 November 2017

Joachim Klisch

4

1 reference

30 November 2017

Martin Schumacher

5

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

43

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1101-1105

1 reference

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Biochemical considerations in1H spectroscopy. Glutamate and glutamine;Myo-inositol and related metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Hepatic and renal contributions to valproic acid-induced hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Carbamoylphosphate synthetase deficiency in an adult: deterioration due to administration of valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Cerebellar involvement in metabolic disorders: a pattern-recognition approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Proton spectroscopy of brain glutamine in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

Molecular water pumps and the aetiology of Canavan disease: a case of the sorcerer's apprentice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42201.X

10.1046/J.1528-1157.2002.42201.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference